The mission of the PRCSG is to conduct high quality clinical trials, of therapeutic agents, in children with rheumatic diseases.
Joined April 2022
- Tweets74
- Following93
- Followers91
- Likes8
PRCSG - 50 Years of Pediatric Rheumatology Research youtu.be/XHhvE2tX0pI?si=vbUD… via @YouTube
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+‐year results from a multicenter, open‐label study - Brunner - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wi…
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial - Brunner - 2026 - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wi…
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial - Brunner - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
PRCSG_network retweeted
🎄 Lace up & save! The Jingle Bell Run is coming, and now’s your chance to join in for less. Use code FALL for $5 off registration — limited time only! 🏃♀️❄️
Run for fun. Run for a cause. 👉 arthr.org/4lT6Cy2
#JingleBellRun
"Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting" — Read it on @ResearchGate: researchgate.net/publication…
25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges - Shishov - 2025 - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
Clinically Inactive Disease and Remission in Patients with Juvenile Idiopathic Arthritis Receiving Tofacitinib: Pos… pubmed.ncbi.nlm.nih.gov/4031…
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations… pubmed.ncbi.nlm.nih.gov/3995…
Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular-Course Juvenile Idiopathic Ar… pubmed.ncbi.nlm.nih.gov/3913…
Efficacy and Safety of Tofacitinib in Patients with Active Systemic Juvenile Idiopathic Arthritis acrabstracts.org/abstract/ef…
Pharmacokinetics of Ustekinumab in Patients with Juvenile Psoriatic Arthritis in a Real‑World Opportunistic Study acrabstracts.org/abstract/ph…
Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients with Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐label, Phase 1 Trial - Brunner - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction - Eloseily - Arthritis Care & Research - Wiley Online Library acrjournals.onlinelibrary.wi…
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study jrheum.org/content/51/11/112…
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthrit… pubmed.ncbi.nlm.nih.gov/3891…
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary re… pubmed.ncbi.nlm.nih.gov/3884…
We invite you to join us for a late breaking poster presentation on Safety and Efficacy of tofacitinib with sJIA @ACRheum on November 18.
Poster L09: November 18, 2024, 10:30 AM – 12:30 PM, Poster Session C, (L01-L14) Late Breaking Posters
We invite you to join us for a poster presentation on PK of ustekinumab in Juvenile Psoriatic Arthritis @ACRheum on November 16.
Poster 0384: November 16, 2024, 10:30 AM – 12:30 PM, Poster Session A, Pediatric Rheumatology – Clinical Poster I